Telomere length shortening in CML is associated with reduced time to accelerated phase but does not influence overall survival.
Main Authors: | Boultwood, J, Watkins, F, Shepherd, P, McGale, P, Richards, S, Fidler, C, Littlewood, T, Peniket, A, Wainscoat, J, Hatton, C |
---|---|
Format: | Journal article |
Published: |
1999
|
Similar Items
-
Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase.
by: Boultwood, J, et al.
Published: (2000) -
Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia.
by: Boultwood, J, et al.
Published: (1999) -
Analysis of telomere length in chronic myelogenous leukemia.
by: Boultwood, J, et al.
Published: (1997) -
Analysis or telomere length in chronic myelogenous leukemia
by: Fidler, C, et al.
Published: (1998) -
Telomere length in myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (1995)